metastasis or drug resistance. These known splicing-related genes include U2AF1, 8 SRSF2, 9 SF3B1, 10 CD44, 11 VEGF 12 and so on.
SNRPA is a 282-amino-acid protein containing 2 RNA-binding domains. The N-terminal RNA-binding domain, along with some flanking amino acids, is required for binding to U1 snRNA. 13 SNRPA is important to form the spliceosome and promote the splicing process of mRNA. It is also involved in the SMN-dependent snRNP biogenesis pathway known to regulate polyadenylation of mRNA. 14, 15 SNRPA is moderately expressed in fat, weakly in muscle, and hardly expressed in small intestine, large intestine, spleen, liver and lung. 16 SNRPA was found to bind the C-terminal portion of importin α, by which SNRPA enters the nucleus independently of de novo snRNA synthesis. 17 As for tumour development, one report has indicated that SNRPA is upregulated in hepatocellular carcinoma by cDNA microarray analysis; 18 however, little is known about its function in human cancer to date.
In this study, we initially found an upregulation of SNRPA expression in GC tissues, which is closely associated with GC progression of patients. Overexpression or knockdown of SNRPA resulted in enhanced or inhibited phenotypes of GC cell growth in vitro and in vivo. Moreover, we demonstrated that NGF, the nerve growth factor, may act as a downstream effect of SNRPA on GC cell growth. 
| ME THODS

| Cell lines and culture conditions
| RNA extraction and quantitative real-time PCR
The relative expression of SNRPA was determined with qRT-PCR with the commercial PrimeScriptTM RT Reagent Kit with gDNA Eraser (TaKaRa, Japan) and SYBR green reagent (TaKaRa, Japan). The total RNA was extracted with TRIzol (Sigma, USA), and reverse transcription was performed with the RNAiso Plus reagent (TaKaRa, Japan). The relative expression was calculated with the double delta comparative CT (2 −∆∆Ct ) method and 
| Establishment of stable cell lines
The lentivirus mediating overexpression of SNRPA (Gene ID: 
| Western blot analysis
Protein extracts of cells were electrophoresed by 10% sodium 
| Cell proliferation assay
Cell proliferation was determined with a commercial Cell Counting 
| Animal experiments
2
| Colony formation assay
Stable cells expressing or silencing SNRPA were seeded, respectively, at a density of 3000 per well in 5 cm dish. Cells were allowed to culture for 2-3 weeks; then, the colonies were stained with crystal violet for 30 minutes, photographed and counted. For soft agar colony formation assay, cells were seeded at density of 1000 per well in 24-well plate in 0.4% low melting agarose over a 1% bottom agarose layer. The culture medium was changed every 3-4 days for up to 2 weeks. The colonies were photographed and counted. All the experiments above were performed as least 3 times in triplicates.
| EdU labelling and immunofluorescence
GC cells were seeded in 24-well culture plates. After 24 hours, cells were incubated with 50 mM 5-ethynyl-2′-deoxyuridine (EdU, RIBOBIO, China) for 2 hours and stained with Apollo ® 567 according to the manufacturer's instruction. The stained cells were observed with microscope and counted. All experiments were independently repeated at least 3 times.
| Global cDNA microarray analysis and target gene verification
The RNA was extracted and reverse transcribed into cDNA as described above, and then sent to KangChen Biotech, Shanghai, Table S1 .
| Statistical analysis
Quantitative values are represented as mean ± standard deviation (±SD), statistical analysis was performed using GraphPad Prism 7.0 software (GraphPad Software, Inc., San Diego, CA, USA) and Student's t test was used to compare values for paired data. The
Kaplan-Meier and log-rank tests were used for the overall survival analysis. P < .05 was considered to be statistically significant.
| RE SULTS
| Elevated SNRPA expression in GC and its association with GC development
SNRPA expression was initially examined by immunohistochemical staining in a GC tissue microarray with specific antibody against SNRPA. As shown in Figure 1A ,B, SNRPA staining was stronger in cancer tissue cohort than that of normal gastric mucosa tissue cohort. Figure S1 ). Taken together, these data suggested that SNRPA expression was increased in GC and was associated with larger tumour size, more advanced pathological stages and worse prognosis.
| Knockdown of SNRPA inhibits cell proliferation of GC cells in vitro
To investigate the role of SNRPA in GC, we first detected the expression levels of SNRPA in 5 kinds of GC cell lines. The western blot data showed that SNRPA was highly expressed in BGC823 and AGS cells (Figure 2A) . Therefore, the 2 cell lines were employed for knockdown experiments whereas SGC7901 and MGC803 cells were employed for overexpression experiments due to the rela- These findings collectively suggested that SNRPA knockdown significantly inhibits cell proliferation of GC cells in vitro.
| Overexpression of SNRPA enhances cell growth in GC
To determine whether SNRPA overexpression promotes cell growth in GC, we generated 2 stable cell lines by infecting 
| SNRPA promotes tumour growth in a xenograft model
To investigate the role of SNRPA on tumourigenicity, the nude mice xenograft model was employed. BGC823-LV-shSNRPA and control cells were injected subcutaneously into 2 separate groups of nude mice (n = 7), respectively. The mice were euthanized and tumour weights were measured after 1 month. As shown in Figure 4A Figure 5C ) and in protein level ( Figure 5D ), demonstrating that NGF was regulated by SNRPA.
To explore the functional relevance of SNRPA and NGF, the si- 
| D ISCUSS I ON
Previous studies have reported that the U1 snRNP complex is involved in a lot of essential activities in eukaryotic cells, such as pre-mRNA splicing and apoptosis. 20, 21 Among its components, in addition to their splicing roles, U1 snRNA molecule is a major target of autoimmunity in SLE-overlap syndromes, 22 U1-70K was shown to be highly associated with apoptosis. 23 However, the roles of U1 snRNP complex and its components in tumourigenesis remain unclear. Our study is the first demonstrating that SNRPA, as a member of U1 snRNP complex, contributes to gastric cancer progression and promote apoptosis and cell survival. 27, 28 NGF is not only discovered in nervous system, but also detected in a variety of normal and neoplastic human tissues. 29 Recently, there have been many researches about the role of NGF in tumour progression. It has been reported that early, sustained sequestration of NGF reduces tumour-induced bone destruction and reduces weight loss in animals with bone cancer. 30 Qing-li LU et al demonstrated that NGF is highly expressed in NSCLC tissues compared with para-cancerous lung tissues. 31 Another recent study indicated that NGF promotes the development of new blood vessels via interacting with α9β1 integrin. 32 NGF has also been shown to promote the EMT process of tumour cells, migration and invasion in pancreatic cancer through the activation of the ERK/CD133 signal cascade and promote gastric cancer tumourigenesis via aberrant cholinergic signalling. 33 In our case, we found that overexpression of SNRPA increased NGF level and knockdown of SNRPA decreased NGF level.
Functionally, NGF knockdown inhibited GC cell growth, in accordance with previous report. More importantly, NGF knockdown attenuated the effect of SNRPA overexpression on the proliferation ability of GC cells. These results may imply that NGF serves as a potential downstream target of SNRPA in human GC. Further study is needed to be done in future in order to reveal the molecular mechanism by which SNRPA regulates the NGF expression in GC cells.
In conclusion, we identified SNRPA as a potential oncogene in GC, which is frequently elevated in tumour tissues and promotes the proliferation ability of GC cells in vitro and in vivo. Our work provided new insights into the treatment strategies against GC and a valuable biomarker for GC diagnosis and prognosis in the future.
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